Patient community and AI mentor
Belong.Life
Belong.Life is queued as a patient-facing condition community and AI health mentor platform. The CAIHL review should examine Dave AI Cancer Mentor, clinical-trial tools, expert/community support, data governance, moderation, and whether patient agency is strengthened or steered.
Public-source research has been drafted, often with AI assistance. No comprehensive human review is recorded unless the profile provenance says so.
Summary judgment · 69% toward patient-directed
Potentially agency-expanding
Condition communities and AI mentors may support patient reflection and peer learning, but sponsored content, research use, trial recruitment, moderation, and commercial alignment need review.
Patient agency
How this tool changes agency
AI answers, expert chats, care-plan reminders, and community support may help patients act if boundaries and evidence quality are clear.
Needs review of app enrollment, data sharing, notification, community, and AI mentor controls.
Patient-facing signals
Who does this AI serve?
Public pages describe cancer and MS patient communities and AI mentors. Belong's own materials also serve patients, providers, pharmaceutical companies, payers, hospitals, advertisers, and clinical-trial sponsors through enterprise and recruitment offerings.
Can patients tell AI is involved?
AI mentor branding is public, but disclosure inside each product flow needs review.
Can patients meaningfully choose?
Needs review of app enrollment, data sharing, notification, community, and AI mentor controls.
Can patients correct or challenge what the AI produces?
Needs review of feedback, correction, content moderation, and expert escalation workflows.
Does it help patients understand or act?
AI answers, expert chats, care-plan reminders, and community support may help patients act if boundaries and evidence quality are clear.
Text findings
Who is left out or burdened?
Not researched
Needs review of languages, condition coverage, digital access, caregiver dynamics, and community moderation burden.
What happens to patient data?
Partially documented, commercial uses disclosed
Privacy policy, revised July 17, 2025, says Belong may use aggregated data and anonymized public posts for research and may deliver advertising or commercial sponsored content from authorized partners. Personal and healthcare information is retained while the account is active and may be deleted by request or account deletion. Medical binder handling, AI prompt retention, and de-identification quality still need review.
Are the clinical boundaries clear?
Not researched
Needs review of AI mentor clinical limits, escalation, emergency guidance, and expert review.
Who defined what good looks like?
Not researched
Needs review of patient-partnered outcomes, clinical validation claims, engagement metrics, and commercial success measures.
Review provenance
Criteria
Same HugoScore CAIHL-derived criteria for every tool; the public criteria are shown on How Reviews Work, displayed from site/data/criteria.json, with fuller method notes in SCORING_FRAMEWORK.md.
Reviewer
AI-assisted public-source draft; no named human reviewer is recorded in the profile data.
AI / model
Not recorded in profile data.
Human review
No comprehensive human review is recorded unless explicitly stated here.
Review date
Jun 12, 2026
Limitations
Initial seed classification updated with a 2026-06-12 factual audit of official product pages and privacy policy. No hands-on testing or full CAIHL review.
Review method
Initial seed classification updated with a 2026-06-12 factual audit of official product pages and privacy policy. No hands-on testing or full CAIHL review.
Draft profile · Low draft, partial public-source check